Vance Thompson is an Ophthalmology physician affiliated with University of South Dakota. OpenAlex indexes 81 publications with 1,545 citations (h-index 21); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
Sponsor: Vance Thompson Vision
- Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure
Sponsor: Vance Thompson Vision
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
49 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Corticosteroid52%Prednisolone Acetate100%Part D<11 patientsalpha-Adrenergic Agonist48%Combigan100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessing ocular dominance: rethinking the current paradigm
Journal of Cataract & Refractive Surgery
2025 - Clinical outcomes of a hydrophobic trifocal diffractive intraocular lens: a literature review
Frontiers in Medicine
2025 - Implantable Collamer Lens Procedure Planning: A Review of Global Approaches
Clinical ophthalmology
2024 - Clinical outcomes of the light-adjustable lens in eyes with a history of prior corneal refractive surgery
Journal of Cataract & Refractive Surgery
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Chien‐Wen Chen
University of South Dakota
Mary Nettleman, MD
University of South Dakota
William Spanos, MD
University of South Dakota
Sabina Kupershmidt
University of South Dakota
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”